Alps Advisors Inc
- SEC CIK
- 0001376113
- Latest filing
- Jul 29, 2026
KROS holding history
Keros Therapeutics, Inc. in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KROS overviewAll 13F holders of KROSFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 18
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −19,673−100.0% | Sold out | Holders |
| Q3 2025 | 19,673 | $311.2K | <0.1% | −2,276−10.4% | Reduced | Holders |
| Q2 2025 | 21,949 | $293.0K | <0.1% | −7,787−26.2% | Reduced | Holders |
| Q1 2025 | 29,736 | $303.0K | <0.1% | −3,020−9.2% | Reduced | Holders |
| Q4 2024 | 32,756 | $518.5K | <0.1% | +4,851+17.4% | Added | Holders |
| Q3 2024 | 27,905 | $1.62M | <0.1% | −239−0.8% | Reduced | Holders |
| Q2 2024 | 28,144 | $1.29M | <0.1% | +2,766+10.9% | Added | Holders |
| Q1 2024 | 25,378 | $1.68M | <0.1% | +5,766+29.4% | Added | Holders |
| Q4 2023 | 19,612 | $779.8K | <0.1% | −2,281−10.4% | Reduced | Holders |
| Q3 2023 | 21,893 | $697.9K | <0.1% | +149+0.7% | Added | Holders |
| Q2 2023 | 21,744 | $873.7K | <0.1% | +2,939+15.6% | Added | Holders |
| Q1 2023 | 18,805 | $803.0K | <0.1% | +118+0.6% | Added | Holders |
| Q4 2022 | 18,687 | $897.4K | <0.1% | +4,665+33.3% | Added | Holders |
| Q3 2022 | 14,022 | $528.0K | <0.1% | −240−1.7% | Reduced | Holders |
| Q2 2022 | 14,262 | $394.0K | <0.1% | −10,409−42.2% | Reduced | Holders |
| Q1 2022 | 24,671 | $1.34M | <0.1% | −2,400−8.9% | Reduced | Holders |
| Q4 2021 | 27,071 | $1.58M | <0.1% | −1,528−5.3% | Reduced | Holders |
| Q3 2021 | 28,599 | $1.13M | <0.1% | −2,088−6.8% | Reduced | Holders |
| Q2 2021 | 30,687 | $1.30M | <0.1% | +30,687 | New | Holders |